Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Gains from Sales and Divestitures: 2018-2019

Historic Gains from Sales and Divestitures for Rockwell Medical (RMTI) over the last 1 years, with Sep 2019 value amounting to $96,542.

  • Rockwell Medical's Gains from Sales and Divestitures was N/A to $96,542 in Q3 2019 from the same period last year, while for Sep 2019 it was $96,542, marking a year-over-year change of. This contributed to the annual value of $98,500 for FY2018, which is N/A change from last year.
  • According to the latest figures from Q3 2019, Rockwell Medical's Gains from Sales and Divestitures is $96,542, which was down 1.99% from $98,500 recorded in Q2 2019.
  • In the past 5 years, Rockwell Medical's Gains from Sales and Divestitures ranged from a high of $98,500 in Q4 2018 and a low of $96,542 during Q3 2019.
  • In the last 2 years, Rockwell Medical's Gains from Sales and Divestitures had a median value of $98,500 in 2019 and averaged $98,010.